1109P Amivantamab vs real-world (RW) therapy in Japanese patients with advanced non-small cell lung cancer (aNSCLC) epidermal growth factor receptor (EGFR) exon-20 insertion mutation (E20i)
| Autor: | Kim, T.M., Girard, N., Low, G.K.M., Zhuo, J., Yu, D.Y., Yang, Y., Murota, M., Lim, C., Kleinman, N.J., Cho, B.C. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1058-S1058 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|